Unknown PHASE3 INTERVENTIONAL NCT00525863

Oxygen Therapy in Schizophrenia

Sponsor: Beersheva Mental Health Center

Interventions oxygen

Updated 6 times since 2017 Last updated: May 26, 2008 Started: Jan 31, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00525863, this PHASE3 trial focuses on Chronic Schizophrenia and remains ongoing. Sponsored by Beersheva Mental Health Center, it has been updated 6 times since 2008, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE3
Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beersheva Mental Health Center
National Alliance for Research on Schizophrenia and Depression

Data source: Beersheva Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beersheva, Israel